![]() | Up a level |
Number of items: 1.
Basu, B, Krebs, MG, Sundar, R, Wilson, RH, Spicer, J, Jones, R, Brada, M, Talbot, DC, Steele, N, Garces, AH Ingles et al (show 18 more authors)
(2018)
Vistusertib (dual m-TORC1/2 inhibitor) in combination with paclitaxel in patients with high-grade serous ovarian and squamous non-small-cell lung cancer.
ANNALS OF ONCOLOGY, 29 (9).
pp. 1918-1925.